M icroRNAs (miRNAs) are small noncoding RNAs (∼20-22 nt) that regulate gene expression via specific targeting of mRNAs for degradation and translation inhibition (1) (2) (3) . A miRNA is initially produced as a long primary transcript (primiRNA), which is processed by the Microprocessor, a complex composed of the ribonuclease Drosha and an RNA-binding protein DiGeorge syndrome critical region gene 8 (DGCR8) (or Pasha, the fly and worm homologs of DGCR8) (4) (5) (6) (7) (8) (9) (10) (11) . The resulting precursor miRNA (pre-miRNA) is exported into the cytoplasm by Exportin-5 where it is processed further by Dicer and subsequently loaded into RISC (RNA-induced silencing complex) (12, 13) . Abundant evidence indicates that pri-miRNA processing is highly regulated during development and is often dysregulated in diseases (1, 14, 15) . For example, p53, lin-28B, and SMAD proteins have been shown to directly regulate the Microprocessor complex (16) (17) (18) . In addition, DiGeorge syndrome is caused by the chromosomal deletion 22q11.2, a section that includes DGCR8 (19) . A mouse model for this deletion shows that haploinsufficiency of Dgcr8 results in abnormal miRNA biogenesis in the brain that contributes to the neurological and behavioral defects associated with DiGeorge syndrome (20, 21) .
Studying pri-miRNA processing in cells has been technically challenging. Mature miRNAs are generally believed to be longlived molecules although accelerated decay for individual microRNAs has been reported (22) . Thus, the abundance of miRNAs often does not change dramatically unless cells grow by proliferation or differentiation. Furthermore, the Drosha-cleavage step is coupled to cell growth in certain cell types (23). Finally, unprocessed pri-miRNAs seem to be degraded quickly via a pathway not well understood, and thus do not greatly accumulate. Two cellular reporter assays for pri-miRNA processing have been previously described. A fluorescence-based assay comprises a GFP-pri-miRNA fusion construct that is stably integrated into various cell lines (24). This assay suffers from the lack of a normalization factor to overcome variability in fluorescent protein expression due to processes unrelated to pri-miRNA processing. The second system uses a firefly luciferase-pri-miRNA fusion and normalizes the firefly luciferase signal to that of Renilla luciferase expressed from a cotransfected plasmid (25). However, as the luciferase expression levels are measured enzymatically in cell lysates, single-cell resolution and real-time experiments cannot be achieved.
An outstanding question about miRNA maturation concerns a potential role for heme in pri-miRNA processing. We previously found that a truncated form of the 773-residue DGCR8 called NC1 (amino acids 276-751) overexpressed in Escherichia coli stably associates with heme (26). Each DGCR8 dimer associates with one heme molecule using a heme-binding domain (HBD) located in its central region (amino acids 276-498) and ligates to the heme iron using the Cys352 residues from both subunits (27, 28). Through mutagenesis analyses, Cys352 and Trp329 have been identified to be important for association with heme (27). We also identified the N-terminal region of the HBD as a dimerization domain (amino acids 276-353) and determined the crystal structures of this domain from human and frog DGCR8 (27) . The structures show that DGCR8 makes an unconventional use of its WW motif for mediating an extensive dimerization interface. Interestingly, Cys352 and Trp329 from both subunits cluster on a common surface, which is likely to serve as a direct binding site for heme. The heme-free C352A, W329A, and W329H NC1 mutants display reduced but still substantial pri-miRNA processing activity in vitro (26, 27) . It is Significance MicroRNAs (miRNAs) have important functions in development and cell physiology. The vast majority of mature miRNAs are produced from primary transcripts of microRNAs (pri-miRNAs) by a multi-step pathway. The first step, cleavage of pri-miRNAs by the Microprocessor complex, is highly regulated but technically challenging to study. We have developed a robust method that faithfully measures pri-miRNA processing efficiency in live cells. Using this assay, we establish an essential function of heme in miRNA maturation, a provocative idea suggested by previous biochemical studies. Our study reveals a previously unknown cellular function of this central biological cofactor, linking metal ion biology with the regulation of noncoding RNAs. Our method should be widely useful for studying RNA processing in biology and diseases.
not clear that, in compartmentalized eukaryotic cells where heme is synthesized in the mitochondrion and DGCR8 functions in the nucleus, heme can really affect pri-miRNA processing.
Here, we report a live-cell pri-miRNA processing assay using a ratiometric fluorescence reporter that allows robust data analyses at single-cell resolution. Using this assay in combination with results from heme-binding analyses, we provide clear evidence that heme is essential for pri-miRNA processing in human cells.
Results
A Fluorescence-Based Live-Cell Pri-miRNA Processing Reporter. We designed a ratiometric reporter construct based on a plasmid that simultaneously expresses two fluorescent proteins, mCherry and eYFP, driven by a bidirectional tetracycline-inducible promoter (Fig. 1A) . This plasmid was generated by Sharp, Mukherji, and co-workers for examining interactions between mature miRNAs and 3′-untranslated regions (UTRs) of target messenger RNAs (29). In our reporter, pri-miRNA sequences were inserted into the 3′-UTR of the mCherry expression cassette whereas the eYFP 3′-UTR was left unaltered. Thus, this construct expresses an mCherry-pri-miRNA fusion RNA. Cleavage of the pri-miRNA moiety of the fusion RNA by Drosha/DGCR8 results in removal of the polyadenylation (poly-A) tail along with a portion of the 3′-UTR, which leads to degradation of the mCherry mRNA and reduction of mCherry protein expression and its fluorescent signal. The eYFP fluorescence signal allows changes of individual cells' transcriptional and translational activities to be normalized. Thus, the mCherry/eYFP ratio should negatively correlate with pri-miRNA processing activity. In this study, we chose to use the reciprocal, the eYFP/mCherry ratio, as it is a positive indicator for pri-miRNA processing efficiency.
As a starting point, we engineered human pri-miR-9-1 and primiR-30a into our fluorescent reporter. HeLa cells transiently transfected with either the pri-miR-9-1 or pri-miR-30a fluorescent reporter showed expression of eYFP and mCherry (Fig.  1B) . Not surprisingly, there was a large intrinsic variation in the expression levels of eYFP and mCherry among cells. The eYFP and mCherry intensities of individual cells had a linear relationship over the range of reporter expression levels achieved, indicating that the reporters make proportional responses to the pri-miRNA processing machinery (Fig. 1C) . No plateauing was observed, suggesting that the reporter system had not saturated the endogenous processing machinery. We calculated the slope from linear regression of the data to measure the overall efficiency of pri-miRNA processing.
We validated the fluorescent reporters by ectopically expressing DGCR8. HeLa cells express DGCR8 at a relatively low level (30); thus, we expected that expression of functional DGCR8 protein from a plasmid would increase the efficiency of primiRNA processing. Cells were cotransfected with a reporter and a plasmid expressing an N-terminal flag-tagged DGCR8 protein (N-flag-DGCR8) (Fig. 1D) . The C-terminal tail of DGCR8 has been shown to be required for pri-miRNA processing (31, 32), and a mutant with the C-terminal tail deleted (ΔCTT) was used as an inactive control (Fig. 1D) . When N-flag-DGCR8 was ectopically expressed, we continually observed a 90% increase in the slope (Fig. 1E and Fig. S1 A, B, D, and E). In contrast, no significant changes in slope were observed in cells expressing the ΔCTT mutant.
We next tested whether the fluorescent signals faithfully indicate the processing of pri-miRNAs in cells. We used quantitative RT-PCR (qRT-PCR) to determine the abundance of the mCherry-pri-miRNA fusion RNAs, the eYFP mRNA and mature miRNA. Consistent with the fluorescence measurements, the eYFP/mCherry-pri-miRNA RNA expression ratio increased by about twofold in cells expressing N-flag-DGCR8 ( Fig. 1F and Fig. S1F ). The levels of mature miR-9 and miR-30a in cells ectopically expressing N-flag-DGCR8 increased to 1.7-and 1.6-fold of those in cells transfected with reporters only (Fig. 1G and Fig. S1G ). HeLa cells do not naturally express miR-9 so the reporter solely contributes the signal, whereas the mature miR30a detected here originates from both the highly expressed endogenous gene and the reporter. We confirmed the mature miR-9 qRT-PCR results using Northern blots (Fig. S1C) . Additionally, we observed an increase in the pre-miR-9 after N-flag-DGCR8 expression, which is consistent with an increase in primiR-9-1 processing (Fig. S1C) . In contrast to the wild-type N-flag-DGCR8, expression of ΔCTT did not cause large changes to the abundance of mCherry-pri-miRNA fusion, mature miR-9, or miR-30a relative to the "reporter only" transfection. Additionally, we tested a pri-miR-9-1 reporter in which the Drosha cleavage site was mutated, and this reporter was unresponsive to N-flag-DGCR8 expression (SI Text and Fig. S2) . These results clearly demonstrate that the fluorescence reporter expression responds to changes in bona fide pri-miRNA processing activity, can detect the processing potential of mutant pri-miRNA, and reflects the function of ectopically expressed N-flag-DGCR8 proteins. The latter observation will be used to examine DGCR8 mutants.
The Reporter Assay Detects Alteration of Endogenous DGCR8 Activity.
We next tested whether our reporter assay was sensitive to perturbation of DGCR8 expression via RNA interference. We Fig. S1 . (F and G) The abundance of the eYFP mRNA, the mCherry-pri-miRNA fusion RNA (F), and mature miR-9 (G) expression levels from E was measured using qRT-PCR (mean ± SD, n = 3). P values are labeled on the graphs.
synthesized an siRNA, siDGCR8-1, that had been previously shown to reduce DGCR8 expression and decrease pri-miRNA processing and the abundance of mature miRNAs (10) (Fig. 2A) . HeLa cells were cotransfected with siDGCR8-1 and the pri-miR-9-1 reporter. siCyclophilin was used as a normalization control. siDGCR8-1 reduced the expression of endogenous DGCR8 mRNA by 50% (Fig. 2B ) and resulted in a 48% decrease in the fluorescence slope (Fig. 2C ). This result indicates that our reporter is sensitive enough to detect a change in pri-miRNA processing efficiency caused by a modest reduction of endogenous DGCR8 expression. Note that the reduction of DGCR8 expression achieved here by RNA interference is similar to the ∼50% decrease observed in a DiGeorge syndrome mouse model (20, 21) .
We also tested whether the pri-miRNA-processing defect caused by siDGCR8-1 could be rescued by expressing N-flag-DGCR8. siDGCR8-1 targets a coding sequence in the C-terminal region of endogenous DGCR8; the N-flag-DGCR8 expression plasmid (pN-flag-DGCR8) contains 10 silent mutations within the siDGCR8-1 targeting site so that siDGCR8-1 does not affect the expression of this exogenous DGCR8 ( Fig. 2A) . Cotransfection of pN-flag-DGCR8 with the reporter and siDGCR8-1 enhanced the total DGCR8 expression to three times the level of the siCyclophilin control (Fig. 2B ) and resulted in an overall eYFP/mCherry slope twice that of siDGCR8-1 only (Fig. 2C ). This result is consistent with a rescue of pri-miRNA processing by expression of N-flag-DGCR8. The siDGCR8-1/pN-flag-DGCR8 data have a large deviation from the fitted line, with an R 2 value of 0.69, much lower than the >0.86 values obtained from most other experiments (Figs. 2 C and D) . In fact, there appeared to be two cell populations, which can be roughly separated by the fit curve (gray dashed line in Fig. 2D ). The lower cell population has a normalized eYFP/mCherry slope of 0.64 (R 2 = 0.89), which is close to that of the siDGCR8-1, whereas the upper cell population displays a normalized slope of 1.64 (R 2 = 0.97), which is close to the slope of N-flag-DGCR8 overexpression, 1.90 (Figs.   2D and 1E) . A control transfection with a fluorescein-labeled siRNA indicated that the siRNA got into most cells. Thus, it is likely that the lower cell population took up the reporter and siDGCR8-1 whereas the upper population received the reporter, pN-flag-DGCR8, and siDGCR8-1. This interpretation is supported by further experiments, in which the amount of pN-flag-DGCR8 used in the transfection was increased from 0.1 to 0.3 μg and the percentage of cells present in the upper population increased correspondingly ( Fig. S3 C and D) . These results demonstrate that a benefit of our fluorescence imaging-based assay is to allow pri-miRNA processing efficiency of different cell populations to be detected.
Overexpression of Drosha Does Not Enhance Pri-miRNA Processing.
We showed that pri-miRNA processing is sensitive to both overexpression and RNAi knockdown of DGCR8. As Drosha and DGCR8 are known to function together, we compared the pri-miRNA processing efficiency of HeLa cells ectopically expressing either Drosha-flag, N-flag-DGCR8, or both. Fluorescence measurements showed that transfection of pCK-Drosha-flag did not increase processing activity, in contrast to the pN-flag-DGCR8 transfection; and coexpression of Drosha and DGCR8 resulted in pri-miRNA processing efficiency either higher than (pri-miR-9-1 reporter) or similar to (pri-miR-30a reporter) N-flag-DGCR8 expression alone (Figs. S4 A and B and S5 A and B). Similarly, mature miR-9 expression did not increase after Drosha-flag expression but did increase to threefold that of the reporter only after N-flag-DGCR8 expression, and to 6.8-fold after coexpression (Fig. S4C) . qRT-PCR analyses indicate that Drosha expression was successful with its mRNA level doubled in the cotransfection with the pri-miR-9-1 reporter and quadrupled with the pri-miR30a reporter (Figs. S4E and S5D ). These changes are modest compared with the 45-to 85-fold increase observed for DGCR8 (Figs. S4D and S5C) but are comparable with the DGCR8 expression level achieved in the cotransfection with siDGCR8-1 where large changes in pri-miRNA processing efficiency were observed (Fig. 2) . Overall, our results seem to suggest that, in HeLa cells, DGCR8, not Drosha, is the rate-limiting factor for pri-miRNA processing. This notion is consistent with the previous reports that the DGCR8 protein is subjected to multiple layers of regulation (5, 30, (33) (34) (35) (36) ).
All Known Heme-Binding-Deficient DGCR8 Mutants Are Defective in Pri-miRNA Processing in HeLa Cells. We used our cellular assay to investigate the role of heme in DGCR8 function. Cys352 is conserved in all DGCR8 family members and serves as the coaxial ligand to the Fe(III) in heme (28). Mutation of Cys352 to an alanine, serine, or histidine residue completely abolishes heme binding to the NC1 protein and reduces its pri-miRNA processing activity in vitro. Therefore, we tested the C352A mutant to examine the importance of heme binding in live cells. We set up a series of cotransfections of the pri-miR-9-1 reporter with pN-flag-DGCR8, either wild type or the ΔCTT or C352A mutants. Compared with the wild type, we observed a 51% decrease in the eYFP/mCherry fluorescence slope for the C352A transfection, which corresponds to a decrease in the processing activity (Fig. 3A) . Similarly, the eYFP/mCherry-pri-miRNA fusion RNA ratio and the mature miR-9 level decreased in the C352A transfection ( Fig. 3 B and C) . In contrast, the fluorescence slope, the mCherry-pri-miR-9-1 fusion RNA and mature miR-9 levels for C352A are very similar to those for the inactive ΔCTT (Fig. 3 A-C) . Furthermore, C352A was expressed at a similar level as the wild type, as shown by Western blotting (Fig. 3D) . Thus, the lack of pri-miRNA processing activity observed for C352A is not due to reduced expression of the mutant protein. Altogether, these results clearly indicate that the DGCR8 C352A mutant is inactive in pri-miRNA processing in HeLa cells.
We subsequently tested additional heme-binding-deficient DGCR8 mutants. The crystal structures of the DGCR8 dimerization domains show that Cys352 and Trp329 cluster on a putative heme-binding surface (27, 37). Mutation of Trp329 to either alanine (the residue at the equivalent position in fly Pasha) or histidine (the residue in worms) in NC1 results in heme-free proteins after overexpression; and both mutants have reduced pri-miRNA processing activity in vitro (27). In addition to Trp329, Pro351 is also important for DGCR8 heme binding. Mutation of Pro351 to Ala greatly reduces the affinity of DGCR8 for heme (28). We therefore tested the activity of P351A, W329A, and W329H using our cellular pri-miRNA processing assay. In our initial experiments, equal amounts of wild-type and mutant plasmids were used in transfections; however, the three mutant proteins were expressed at slightly lower levels than the wild type. Thus, we doubled the amounts of the mutant plasmids in the transfections and achieved protein expression levels nearly equal to that of the wild type (Fig. 3E ). Under the latter condition, all three mutants displayed normalized fluorescence slopes and eYFP/mCherrypri-miR-9-1 fusion RNA ratios significantly lower than that of Nflag-DGCR8 but similar to ΔCTT (Fig. 3 F and G). Mature miR-9 levels decreased an average of 50% for all mutants relative to the wild type, again similar to that of ΔCTT (Fig. 3H ). We tested these heme-binding-deficient mutants using the pri-miR-30a reporter construct and obtained similar results (
Altogether, these data clearly demonstrate that all known hemebinding-deficient DGCR8 mutants are defective in pri-miRNA processing in HeLa cells.
An "IPCL" Motif Is Required for Heme Binding and for Pri-miRNA
Processing. The unique properties of DGCR8 encouraged us to search for motifs that are important for heme binding. The residues in the vicinity of Pro351 and Cys352 show a high degree of conservation among DGCR8 family members (Fig. 4A ). Ile350 and Leu353 are invariable, Ser349 is conserved except in shrimp and insects, and His354 is conserved except in shrimp, insects, and worms. We mutated Ser349, Ile350, Leu353, and His354 to alanine in the context of NC1 and examined their heme-binding properties through overexpression in E. coli and purification using our routine procedures. The I350A and L353A mutations nearly abolished the presence of heme in purified NC1 proteins, and the mutant heme-free proteins cannot bind heme in vitro to reconstitute the complexes ( Fig. S7 and Table  S1 ). In contrast, purified S349A and H354A NC1 dimer proteins were occupied by heme, resembling the wild type. We then introduced these mutations to pN-flag-DGCR8 and tested their activity using the pri-miR-9-1 reporter. We found that S349A and H354A were active and that I350A and L353A were inactive in HeLa cells, as judged by the eYFP/mCherry fluorescence ratios ( Fig. 4B and Fig. S8 ) and mature miR-9 levels (Fig. 4C ). All DGCR8 point mutants were expressed at roughly equal levels as determined by qRT-PCR except for L353A, which had a higher expression level similar to the ΔCTT mutant (Fig. 4D ). The nearly perfect correlation between heme binding, pri-miRNA processing, and sequence conservation observed in our mutagenesis analyses strongly supports an essential function of heme in the miRNA maturation pathway in animals.
Heme Availability and Biosynthesis in HeLa Cells Affects Pri-miRNA Processing. We tested whether cellular heme availability affects pri-miRNA processing activity using our cellular reporter assay.
We cultured HeLa cells in heme-depleted media and compared their pri-miRNA processing efficiency with and without 10 μM hemin as supplement. The eYFP/mCherry fluorescence slope for cells grown under the heme-replenished condition had a modest but statistically significant increase (normalized slope = 1.11, P = 0.0012), which indicates an increase in pri-miRNA processing efficiency (Fig. 5A) . Importantly, the mature miR-9 level nearly doubled in the presence of hemin, suggesting that alteration in heme availability in cellular environments can make large differences in mature miRNA levels (Fig. 5B) . We also measured the amount of newly synthesized heme and observed a 60% reduction upon hemin treatment (Fig. 5C ). This result is not surprising, as heme biosynthesis is known to be regulated via a feedback mechanism. Measurements of eYFP mRNA levels suggest that increase in miR-9 abundance by hemin was not caused by an enhanced rate of transcription (Fig. 5D ).
We next examined the effects of inhibiting endogenous heme biosynthesis on pri-miRNA processing. We cultured HeLa cells under the heme-depleted condition, as described above, and treated them with 1 mM succinylacetone (SA). SA is a cellpermeable inhibitor of aminoluvelinic acid dehydratase, an enzyme responsible for the second step in the heme biosynthesis pathway (38). In a parallel experiment, the heme deficiency was rescued via addition of 10 μM hemin. To reduce secondary effects, we limited the duration of heme biosynthesis inhibition to 10 h. SA effectively reduced the amount of newly synthesized heme to about 25% that of no-treatment cells (Fig. 5C ) and resulted in a 12% decrease in the eYFP/mCherry fluorescence slope, which corresponds to a decrease in pri-miRNA processing activity (Fig. 5A ). The addition of SA did not decrease the levels of mature miR-9 compared to that with no treatment (Fig. 5B ). However, we observed an increase in eYFP mRNA level after SA treatment, which suggests that the mCherry-pri-miR-9 transcription is likely to have increased under this condition (Fig.  5D ). The lack of change in miR-9, despite the increased pri-miR-9-1 transcription, suggests that processing efficiency decreased after SA treatment. The lack of changes in miR-9 could also be contributed by a reduction of cell growth, an effect known to associate with inhibition of heme biosynthesis (39). The addition of exogenous hemin along with SA reversed the change in eYFP/ mCherry fluorescence slope to a 17% increase relative to SAtreated cells (Fig. 5A) , and the abundance of mature miR-9 doubled relative to those under both no-treatment and SA conditions (Fig. 5B) . Because the changes of pri-miRNA processing efficiency caused by hemin and SA treatments were relatively small, we repeated these experiments and analyzed the RNAs using Northern blots. The trends in mature miR-9 levels were confirmed (Fig. S9E) . Additionally, we observed an increase of the mCherry-pri-miR-9-1 fusion RNA upon SA treatment, which was reversed by hemin (Fig. S9E) . Based on these observations, we conclude that both heme availability from extracellular environments and endogenous heme biosynthesis positively affect pri-miRNA processing. These effects are most likely to be exerted via the DGCR8-heme interaction. As the reduced primiRNA processing caused by inhibition of endogenous heme biosynthesis can be rescued by addition of hemin to the media, the origin of heme does not seem to be critical.
Discussion
Here, we present a robust cellular assay for monitoring primiRNA cleavages. The assay is sensitive to both ectopic expression and RNA interference of the pri-miRNA processing machinery and thus can detect both increases and decreases in processing efficiency. The use of single-cell analyses and normalization with eYFP results in a sensitive and accurate reporter. Our assay enables us to isolate pri-miRNA processing efficiency from complex biological processes and diseases. With this technical advance, a multitude of questions about the Microprocessor complex could be investigated, including regulation of the Microprocessor and structural features of pri-miRNAs required for efficient processing (40, 41).
Using this assay we have analyzed the function of heme in miRNA maturation. Through a series of mutagenesis, we found that the six heme-binding-deficient DGCR8 mutants are defective in pri-miRNA processing. This correlation between heme binding and pri-miRNA processing in DGCR8 strongly argues for an essential function of heme in miRNA maturation. This conclusion is further strengthened by the observation that hemin activates primiRNA processing in HeLa cells cultured in heme-depleted media; and a heme biosynthesis inhibitor decreases processing. Because the heme-binding residues are highly conserved in animals (37), we speculate that the heme is also required in DGCR8 homologs.
We identified a previously uncharacterized heme-binding motif, IPCL. This motif shares similarity to the heme regulatory motif (HRM), which contains Cys-Pro, but in the opposite order. HRM directly binds heme and is found in repeats in a range of heme-regulated proteins such as the yeast transcription activator HAP1, the human δ-aminolevulenic acid synthase, and heme oxygenase-2 (42). It is possible that, in both motifs, the proline helps position the cysteine side chain in an appropriate geometry for ligation and for catalytic or regulatory functions. The conserved motif IPCL is essential but not sufficient for DGCR8 to associate with heme, as the dimerization subdomain, including Trp329 in the WW motif, and the C-terminal region of the HBD are also required for high-affinity association with heme. A bioinformatics search of protein sequences that contain both WW motif and IPCL yielded only DGCR8 homologs.
We show that heme is necessary for DGCR8 activity in live cells. What is the function of the DGCR8-heme interaction? There are two major possibilities that are not mutually exclusive. First, DGCR8 may be directly regulated by the availability of heme (43). In support of this possibility, we have shown previously that Fe(III) heme, but not the Fe(II) form, activates the pri-miRNA processing activity of DGCR8 in vitro (34) and here that heme availability and biosynthesis affect pri-miRNA processing efficiency in HeLa cells. Furthermore, heme oxygenase-1 (HO-1) was shown to reduce the total pool of cellular mature miRNAs and pre-miRNAs, in addition to blocking the induction of muscle-specific miRNA in myoblasts (44). HO-1 degrades heme in response to various stress conditions. Although the increased miRNA level was attributed to decreases in DGCR8 protein levels, this observation is also consistent with reduced activation of the DGCR8 protein caused by increased heme degradation. As heme is synthesized in cells as the Fe(II) form, oxidation of the heme iron may also affect pri-miRNA processing.
The second possibility is that the heme bound to DGCR8 serves a structural purpose. We have shown that DGCR8 binds Fe(III) heme very tightly, making it hard to act as a reversible sensor of heme. Although the observation that reduction of the heme bound to DGCR8 to the Fe(II) state renders the protein inactive in primiRNA processing suggests a redox regulation, the reduction requires long incubation (30-60 min) with a strong reductant dithionite (34). Thus, reversible redox switch of the DGCR8-bound heme is unlikely to occur under physiological conditions. Additionally, the dual-cysteine ligation of the Fe(III) heme by DGCR8 makes the heme unavailable for potential catalytic functions. These hypotheses should be tested in the future.
Materials and Methods
Additional procedures can be found in SI Materials and Methods.
Vectors and Cloning. The pri-miRNA processing reporters were engineered based on the bidirectional tetracycline-inducible vector containing mCherry and eYFP (pTRE-BI-red/yellow) (29). Fragments of pri-miR-9-1 (143 nt) and pri-miR-30a (148 nt) were PCR-amplified from human genomic DNA and subsequently cloned into pTRE-BI-red/yellow.
Cell Culture and Transfection. The HeLa Tet-On cell line was purchased from Clontech. HeLa Tet-On cells were cultured in DMEM (Life Technologies) with 5% Tet-system approved FBS (Clontech) in 5% CO 2 at 37°C. Cells were transfected with Effectene (Qiagen) following manufacturer's instructions.
Imaging and Analysis. All imaging was performed using a Nikon Eclipse Ti microscope equipped with an EMCCD camera (Andor iXon). We wrote a program based on the Matlab software package (The MathWorks) for integrating fluorescence intensities of individual cells, which is described in SI Materials and Methods.
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SI Text
Determining Processing Competency of Pri-miRNAs in Cells. We tested whether the reporter assay can distinguish a processingincompetent primary transcript of microRNA (pri-miRNA) mutant from the wild type. Pairing interaction around the Drosha cleavage sites in pri-mRNAs has been shown to be critical for processing (1) . We mutated four residues around the 5′ Drosha cleavage site in the pri-miR-9-1 reporter to generate the M1 construct (Fig. S4A) . Cotransfection of the M1 reporter with pN-flag-DGCR8 did not show the large increase in slope that was observed for the wild type ( Fig. S4 B and C) . Cotransfection with ΔCTT also did not exhibit significant changes. The lack of changes in processing of pri-miR-9-1 M1 by ectopic expression of N-flag-DGCR8 was confirmed by measurements of mCherrypri-miR-9-1 fusion and eYFP mRNA levels using quantitative RT-PCR (qRT-PCR) (Fig. S4D) . These results indicate that our reporter assay detects legitimate pri-miRNA cleavage events and may be used to examine processing competency of pri-miRNAs in cells.
SI Materials and Methods
Reagents. Succinylacetone (synonym 4,6-Dioxoheptanoic acid), doxycycline, and horse skeletal muscle apomyoglobin were from Sigma-Aldrich. Hemin was from MP Biomedicals. δ-Aminolevulinic acid (δ-ALA) was from either MP Biomedicals or Frontier Scientific. The siRNAs were purchased from Dharmacon, Thermo Scientific. The 4-14 C-aminolevulinic acid was a gift from Li Zhang (University of Texas at Dallas). Mature miR-9 Locked Nucleic Acids (LNA) probe was obtained from Exiqon.
Vectors and Cloning. The pri-miRNA processing reporters were engineered based on the bidirectional tetracycline-inducible vector containing mCherry and eYFP (pTRE-BI-red/yellow), both fused to an N-terminal nuclear localization signal sequence (2) . Fragments of pri-miR-9-1 (143 nt) and pri-miR-30a (148 nt) were PCR-amplified from human genomic DNA. The primers were as follows with the ClaI and NotI cloning sites underlined: pri-miR-9-1 forward (ACCATCGATGGCTGCGTGGAAGA-GGCGG), pri-miR-9-1 reverse (TGCAGCGGCCGCCTGCA-GCCCCTCTGCGCAGT), pri-miR-30a forward (ACCATCG-ATGGAAAGAAGGTATATTGCT), pri-miR-30a reverse (TGC-AGCGGCCGCAAACAAGATAATTGCTCCT).
The amplified pri-miRNAs were initially cloned into the ptre2hyg-HA vector (Clontech) between the ClaI and NotI sites for the purpose of a different study. The pri-miRNAs were subsequently excised using ClaI and SalI and inserted into pTRE-BI-red/yellow. The pri-miR-9-1 M1 mutant was made using the QuikChange site-directed mutagenesis protocol (Qiagen). Mutagenesis of N-flag-DGCR8 and NC1 expression constructs was carried out using the standard four-primer PCR method. The RNA-and protein-coding sequences of all plasmids were confirmed by sequencing.
Cell Culture and Transfection. The HeLa Tet-On cell line was purchased from Clontech. HeLa Tet-On cells were cultured in DMEM (Life Technologies) with 5% Tet-system approved FBS (Clontech) in 5% CO 2 at 37°C. For transfections without siRNAs, 4.8 × 10 5 cells were seeded on 35-mm glass-bottom plates. The following day, cells were transfected with 0.4 μg of total DNA or 0.8 μg for low expression constructs using the Effectene reagent (Qiagen). Cells were immediately induced with 2 μg/mL doxycycline and imaged 18-24 h later unless specified otherwise. Media with phenol red were used for transfection and induction and were exchanged for a clear medium without the dye and containing 2 μg/mL doxycycline immediately before imaging.
Cotransfection of reporter and siRNAs was performed using the DharmaFECT Duo transfection reagent (Thermo Scientific) following the manufacturer's instructions. The final concentrations of siRNA and plasmid were 100 nM and 2 μg/mL, respectively. The sequence of siDGCR8-1 was the same as reported by Kim and coworkers (3). Cells were passaged 1 d posttransfection, plated on 35-mm glass-bottom plates, and 4 h later induced with 2 μg/mL doxycycline. Cells were imaged 18-24 h postinduction.
Heme-depleted media was made by treating Tet-system approved FBS with 0.1 M ascorbic acid for 2 h (4). The absorbance spectrum of the FBS was recorded at the beginning and throughout the treatment to monitor the disappearance of the 405-nm heme peak. The ascorbic acid was removed by dialyzing against 1 L of phosphate buffered saline (PBS, containing 137 mM NaCl, 2.7 mM KCl, 10 mM Na 2 HPO 4 , and 1.8 mM KH 2 PO 4 ) at room temperature using dialysis tubing with a molecular mass cutoff of 12,500 Da twice for 1 h each round. Heme-depleted FBS was added to DMEM, and the medium was sterile-filtered. Cells were cultured in heme-depleted media for 24 h and split into either six-well plates or glass-bottom imaging plates. For primiRNA processing reporter assays, cells were transfected with Effectene. Either 1 mM succinylacetone (dissolved in water), 10 μM hemin (dissolved in DMSO), or both was added to the cell cultures at the same time as doxycycline. After 10 h, cells were either imaged or lysed for RNA extraction.
Measuring Rates of Heme Biosynthesis. To measure reduction in heme synthesis during succinylacetone/heme treatments, we added to the media 0.4 μCi of 4-14 C-aminolevulinic acid and 20 μM unlabeled δ-ALA. After 10 h, cells were washed twice with PBS, scraped into a 2-mL tube, and spun down at 13,226 × g for 1 min. Cells were resuspended in 0.3 mL of heme extraction buffer containing 80% (vol/vol) acetone and 0.5 M HCl. Then, 1.2 mL of diethyl ether was added, and the cells were spun down at 13,226 × g for 5 min at 4°C. Two additional rounds of extraction with 2 M HCl were performed, and the final aqueous layer was added to a scintillation vial and allowed to evaporate overnight. The following day, 5 mL of scintillation fluid was added, and the amounts of 14 C-labeled heme were measured using a Beckman LS6500 liquid scintillation counter. Three biological replicates were performed, and the counts were normalized to the average of "no-treatment" samples.
Imaging and Analysis. All imaging was performed using a Nikon Eclipse Ti microscope equipped with an EMCCD camera (Andor iXon). We used a 20× air objective (NA = 0.45, Olympus) and lamp illumination (Nikon) at full power, an exposure time of 100 ms and 0 gain. The fluorescence signal was detected using filter cubes for eYFP (510 ± 10 nm band pass excitation and 535 ± 15 nm band pass emission) and mCherry (535 ± 25 nm band pass excitation and 610 ± 10 nm band pass emission). Images were saved as 16-bit tiff files.
We wrote a program based on the Matlab software package (The MathWorks) for integrating fluorescence intensities of individual cells. To determine the perimeter of individual nucleus (segmentation), our program imports individual pairs of eYFP and mCherry images and converts them to binary maps using user-defined threshold values. A value of 1 in the map indicates that the pixel is inside the nucleus, and 0 indicates outside. We usually choose threshold values that maximize the number of cells detected. The perimeter of the nucleus is determined for each image separately, and then an adequate perimeter is chosen for the two images based on the following criteria. If the same cell is found in both images, the smaller perimeter is chosen to avoid including cytosols, which sometimes have low fluorescent signals. If a cell is detected in only one image, the perimeter is kept, allowing for very dim cells that are not detected in both images to be included. The center of the final perimeter for each cell is determined. After the nuclear perimeters are determined, further analysis is done on the original images. A background fluorescence value is calculated for each image by averaging the intensities of the pixels outside the identified nuclei. The background is then subtracted from the intensities of all pixels. The total intensity of an individual cell is calculated as the sum of the pixel intensities within the perimeter. Users can use the center coordinates in the output to remove dead cells or multiple cells detected as one object.
A list of total eYFP and mCherry intensities for individual cells was compiled in Microsoft Excel. Scatter plots were made for eYFP versus mCherry signals. The data were sorted based on each point's distance from the origin. Ten percent of the data with the highest intensities were removed, as they tend to dominate and possibly skew the linear fit. The final datasets were imported into Matlab and fit using the curve fit toolbox. P values were determined using the linear fit function of PRISM (GraphPad, version 4).
qRT-PCR for RNA Analyses. Total RNAs were extracted using the miRNeasy Mini kit (Qiagen) and were digested on-column using the RNase-free DNase set (Qiagen). The reverse transcription (RT) reactions were set up using SuperScript II (Life Technologies), and the quantitative PCR (qPCR) was performed using Platinum SYBR Green qPCR Supermix-UDG (Life Technologies). Following are a list of primers used for RT and qPCR reactions: mCherry RT (TGTCAGGCAACCGTATTCACCGTTCGTACT-GTTCCACGA), eYFP RT (TGTCAGGCAACCGTATTCACC-ACTCCAGCAGGACCATGTGAT), mCherry qPCR forward (ACTACGACGCTGAGGTCAA), eYFP qPCR forward (AA-GATCCGCCACAACATCGA), and qPCR reverse for mCherry and eYFP (TGTCAGGCAACCGTATTCACC).
To prevent potential plasmid in the RNA samples from interfering with the qPCR reactions, the RT primers were designed to include a 21-nt 5′-overhang (shown above in italics). The qPCR reverse primer sequence was identical to this overhang whereas the forward primers were gene-specific. A three-step qPCR reaction was performed with an annealing temperature of 60°C. qPCR results were analyzed using the MxPro software (Stratagene). We calculated the ΔC t values of the mCherry and eYFP transcripts and determined the fold changes by normalizing to the reporter only control.
Mature miR-9 and miR-30a (miR-9-5p and miR-30a-5p in the current miRBase nomenclature) were detected using TaqMan miRNA reverse transcription and miRNA Assay kits (Life Technologies) following the manufacturer's instructions. Ten nanograms of total RNA was used in each reverse transcription. C t values were subtracted by those of either U6 small nuclear RNA or β-actin mRNA. Fold changes were calculated and normalized to the reporter-only control. DGCR8 expression was detected using a Taqman gene expression assay (Life Technologies), with RT performed using a random primer set and SuperScipt II (Life Technologies). The C t values were subtracted by those of β-actin mRNA, and the fold change was calculated and was normalized to that of the siCyclophillin control transfection. All P values were calculated using a two-tailed Student t test except in Fig. 2B where a one-tailed t test was used.
Northern Blotting. Total RNA samples were prepared using the TriZol reagent (Invitrogen) according to the manufacturer's instructions. RNA quality and relative concentrations were determined using 1% agarose gels. Three to 20 μg of RNAs were loaded onto 15% polyacrylamide gels containing 7 M urea and separated by electrophoresis. RNA was transferred to Hybond-N+ membranes (GE Healthcare) and was cross-linked using UV light. The probe for U6 snRNA is a DNA oligo with the sequence 5′-AACGCTTCACGAATTTGCGT-3′. The probes were 5′-labeled with γ-32 P-ATP and were hybridized to membranes in ULTRAhybOligo hybridization buffer (Life Technology) at 42°C overnight. The membranes were washed and exposed to phosphorimagers. The images were recorded using a Typhoon Variable Mode Imager, and the bands were quantified using the program Quantify One (version 4.4.1; Bio-Rad). The plotting was performed using the program PRISM (version 4.0; GraphPad).
Immunoblotting. HeLa cells were transfected with the wild-type and mutant pN-flag-DGCR8 plasmids using Effectene (Qiagen) following standard protocol. Twenty-four hours posttransfection, cells were washed twice with PBS, scraped into 200 μL of PBS, and pelleted by centrifugation at 1,000 × g for 2 min at 4°C. The PBS was removed, and ∼1 × 10 6 cells were resuspended in 80 μL of cold Buffer A [10 mM Hepes-KOH (pH 7.9), 1.5 mM MgCl 2 , 10 mM KCl, 0.5 mM DTT, 0.2 mM phenylmethylsulfonyl fluoride (PMSF)]. Cells were incubated on ice for 10 min and then vortexed for 10 s and pelleted by centrifugation at 16,000 × g for 10 s at 4°C. The supernatant (cytoplasmic fraction) was transferred to a new tube. The pellet was resuspended in 50 μL of Buffer C [20 mM Hepes-KOH (pH 7.9), 25% glycerol, 420 mM NaCl, 1.5 mM MgCl 2 , 0.5 mM DTT, 0.2 mM PMSF] and incubated on ice for 20 min. Cells were pelleted by centrifugation at 16,000 × g for 2 min at 4°C. The supernatant (nuclear fraction) was transferred to a new tube and processed for immunoblotting following our standard procedure (5). The membranes were first incubated overnight with mouse anti-FLAG antibodies (Sigma; diluted 1:1,000) followed by a 2-h incubation at room temperature with anti-mouse antibodies conjugated with horseradish peroxidase (HRP) (Novagen) (1:30,000 dilution). The membrane was washed thoroughly in PBST (PBS with 0.2% Tween-20), and the ECL Plus Western Blotting Detection System (GE Healthcare) protocol was then used according to the manufacturer's instructions. The images were recorded using chemifluorescence and the Typhoon Variable Mode Imager (GE Healthcare).
Expression, Purification, and Characterization of Recombinant NC1
Proteins. Human NC1 (wild type and mutants) proteins were expressed and purified as previously described (6) . Briefly, they were expressed in Escherichia coli BL21(DE3) CodonPlus cells (Stratagene) grown in LB media supplemented with 1 mM δ-ALA at the time of induction. These proteins were purified using cation exchange followed by size exclusion chromatography. The purified proteins were stored in a buffer containing 20 mM Tris, pH 8.0, 400 mM NaCl, and 1 mM DTT. Electronic absorption spectra were recorded on a Beckman-Coulter DU800 spectrophotometer at 25°C.
Heme dissociation and association assays were performed as described (7), in a buffer containing 20 mM Tris, pH 8.0, 400 mM NaCl, and 1 mM DTT. Fe(III) heme-bound NC1 S349A and H354A mutants, at 5.75 and 4.0 μM dimer concentrations, respectively, were incubated at room temperature with eightfold molar excess of apomyoglobin, which has an extremely high affinity for heme, with K D of 3 × 10 −15 M, and serves as a heme sink. Electronic absorption spectra were recorded over a period of 24 h. No heme transfer from NC1 mutants to apomyoglobin was observed. For heme association with the heme-free NC1 mutant dimers, I350A and L353A, 5 μM of the proteins were titrated with up to 10 μM Fe(III) heme, and electronic absorption spectra were recorded. Hemin chloride was converted to Fe(III) heme by dissolving it in 1.4 M NaOH at 10 mM concentration and incubating in the dark at room temperature for >30 min.
This concentrated solution was then diluted in water to give a 100-μM stock solution. No absorption peaks were observed around 450 nm, where the signature DGCR8-Fe(III) heme Soret peak is located. qRT-PCR analyses of eYFP and mCherry-pri-miR-9-1 fusion RNAs from the experiments using the M1 reporter. Shown are average ± SD (n = 3). The slight changes, relative to the reporter-only control, are not statistically significant, with P value(N-flag-DGCR8) = 0.63 and P value(ΔCTT) = 0.93. . Additional data to show that the reporter assay detects alteration of endogenous DGCR8 activity. (A and B) Scatter plots of eYFP vs. mCherry fluorescent intensities from the cotransfection of the pri-miR-9-1 reporter with siCyclophilin (A) or siDGCR8-1 (B), as described in Fig. 2C . The ratio of y and x axes was set at 4:1 for all scatter plots. (C) Scatter plots for cotransfections of the pri-miR-9-1 reporter, siDGCR8-1, and pN-flag-DGCR8. The amount of pN-flag-DGCR8 was varied whereas the amount of reporter was changed correspondingly to keep the total mass of plasmids to 0.4 μg, as required by the Effectene transfection protocol. The cells were assigned to the two groups based on the same gray dashed line as the linear regression fit for the data shown in Fig. 2D (slope = 2.9). (D) The percentage of data points that fell above and below the gray dashed line in C. We believe that cells above the line received pN-flag-DGCR8 whereas those below did not. 
